Search research articles
Contact Us
Filters
Showing results (941-950 of 973) with videos related to
Page
of 98
Sort By:
The Lancet. Gastroenterology & Hepatology
|
January 22, 2022
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
Ahmed Omar Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, et al.
JAMA Neurology
|
March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial
Jeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Nature Communications
|
October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers
Sherille D Bradley, Amjad H Talukder, Ivy Lai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 21, 2022
Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation
Eugene J Koay, Mohamed Zaid, Maureen Aliru, et al.
Physical Biology
|
November 27, 2014
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer
Eugene J Koay, Flavio E Baio, Alexander Ondari, et al.
Scientific Data
|
December 18, 2024
Active and passive organic carbon fluxes during a bloom in the Southern Ocean (South Georgia)
William Major, Sarah L C Giering, Joanna Ainsworth, et al.
Gastroenterology
|
July 29, 2019
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
Yongde Luo, Yaying Yang, Muyun Liu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALS
Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Journal of Hematology & Oncology
|
April 17, 2025
KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
Mahmoud Yousef, Abdelrahman Yousef, Mark W Hurd, et al.
Breast Cancer Research : BCR
|
January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
A DeMichele, A C Dueck, D Hlauschek, et al.
Page
of 98
Search research articles
Search
Showing results (941-950 of 973) with videos related to
Sort By:
Page
of 98
The Lancet. Gastroenterology & Hepatology
|
January 22, 2022
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
Ahmed Omar Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, et al.
JAMA Neurology
|
March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial
Jeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Nature Communications
|
October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers
Sherille D Bradley, Amjad H Talukder, Ivy Lai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 21, 2022
Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation
Eugene J Koay, Mohamed Zaid, Maureen Aliru, et al.
Physical Biology
|
November 27, 2014
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer
Eugene J Koay, Flavio E Baio, Alexander Ondari, et al.
Scientific Data
|
December 18, 2024
Active and passive organic carbon fluxes during a bloom in the Southern Ocean (South Georgia)
William Major, Sarah L C Giering, Joanna Ainsworth, et al.
Gastroenterology
|
July 29, 2019
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
Yongde Luo, Yaying Yang, Muyun Liu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALS
Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Journal of Hematology & Oncology
|
April 17, 2025
KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
Mahmoud Yousef, Abdelrahman Yousef, Mark W Hurd, et al.
Breast Cancer Research : BCR
|
January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
A DeMichele, A C Dueck, D Hlauschek, et al.
Page
of 98